Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anticipating the Next Chess Move: Blocking SARS-CoV-2 Replication and Simultaneously Disarming Viral Escape Mechanisms. | Genes (Basel) | 2022 | 36421821 | PubTator, text mining | PubMed |
| Gold-Based Metal Drugs as Inhibitors of Coronavirus Proteins: The Inhibition of SARS-CoV-2 Main Protease by Auranofin and Its Analogs. | Biomolecules | 2022 | 36421689 | PubTator, text mining | PubMed |
| Shared 6mer Peptides of Human and Omicron (21K and 21L) at SARS-CoV-2 Mutation Sites. | Antibodies (Basel) | 2022 | 36412834 | PubTator, text mining | PubMed |
| The Potential Protective Role of GS-441524, a Metabolite of the Prodrug Remdesivir, in Vaccine Breakthrough SARS-CoV-2 Infections. | Intensive Care Res | 2022 | 36407474 | PubTator, text mining | PubMed |
| Virtual screening based on the structure of more than 105 compounds against four key proteins of SARS-CoV-2: MPro, SRBD, RdRp, and PLpro. | Inform Med Unlocked | 2022 | 36406927 | PubTator, text mining | PubMed |
| The BBIBP-CorV inactivated COVID-19 vaccine induces robust and persistent humoral responses to SARS-CoV-2 nucleocapsid, besides spike protein in healthy adults. | Front Microbiol | 2022 | 36406456 | PubTator, text mining | PubMed |
| Plasma metabolomics and gene regulatory networks analysis reveal the role of nonstructural SARS-CoV-2 viral proteins in metabolic dysregulation in COVID-19 patients. | Sci Rep | 2022 | 36404352 | PubTator, text mining | PubMed |
| Rotavirus vaccine clinical trials: a cross-sectional analysis of clinical trials registries. | Trials | 2022 | 36397105 | PubTator, text mining | PubMed |
| Translation suppression underlies the restrained COVID-19 mRNA vaccine response in the high-risk immunocompromised group. | Front Immunol | 2022 | 36389788 | PubTator, text mining | PubMed |
| Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages. | Front Immunol | 2022 | 36389747 | PubTator, text mining | PubMed |
| Identification and characterization of alternative sites and molecular probes for SARS-CoV-2 target proteins. | Front Chem | 2022 | 36385993 | PubTator, text mining | PubMed |
| XNAzymes targeting the SARS-CoV-2 genome inhibit viral infection. | Nat Commun | 2022 | 36385143 | PubTator, text mining | PubMed |
| Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics. | 3 Biotech | 2022 | 36382241 | PubTator, text mining | PubMed |
| Insight into SARS-CoV-2 Omicron variants in Saudi Arabian genomic isolates. | Saudi Med J | 2022 | 36379532 | PubTator, text mining | PubMed |
| Persistent Laplacian projected Omicron BA.4 and BA.5 to become new dominating variants. | Comput Biol Med | 2022 | 36379191 | PubTator, text mining | PubMed |
| Identification of potent compounds against SARs-CoV-2: An in-silico based drug searching against Mpro. | Comput Biol Med | 2022 | 36370580 | PubTator, text mining | PubMed |
| In Silico Genome Analysis Reveals the Evolution and Potential Impact of SARS-CoV-2 Omicron Structural Changes on Host Immune Evasion and Antiviral Therapeutics. | Viruses | 2022 | 36366559 | PubTator, text mining | PubMed |
| Molecular Dynamics Simulations to Decipher the Role of Phosphorylation of SARS-CoV-2 Nonstructural Proteins (nsps) in Viral Replication. | Viruses | 2022 | 36366534 | PubTator, text mining | PubMed |
| Porcine Epidemic Diarrhea Virus: An Updated Overview of Virus Epidemiology, Virulence Variation Patterns and Virus-Host Interactions. | Viruses | 2022 | 36366532 | PubTator, text mining | PubMed |
| Interferon-Inducible Transmembrane Protein 3 (IFITM3) Restricts Rotavirus Infection. | Viruses | 2022 | 36366505 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=36